We are live on ! Find out more
LXRX icon

Lexicon Pharmaceuticals
LXRX

103 hedge funds and large institutions have $1.02B invested in Lexicon Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 103 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
103
Holders Change
+103
Holders Change %
–
% of All Funds
3.35%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
103
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

LXRX Hedge Fund Activity: Q2 2013 in Review

103 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Lexicon Pharmaceuticals (LXRX) for Q2 2013, worth a combined $1.02B.

Buyers outnumbered sellers: 103 funds opened new LXRX positions and 0 closed out — a net gain of 103 holders — while 0 added to existing stakes and 0 trimmed.

  • 103 institutional investors held Lexicon Pharmaceuticals (LXRX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.02B of Lexicon Pharmaceuticals stock for Q2 2013.
  • 103 funds opened new Lexicon Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +103 holders.

Based on aggregated 13F filings for Q2 2013.